Navigation Links
Stenting May Equal Bypass for Diabetic Heart Patients
Date:11/25/2009

But study follow-up period was too short to draw definite conclusions, experts say,,

WEDNESDAY, Nov. 25 (HealthDay News) -- In diabetic patients with blocked coronary arteries, there appears to be no difference in outcomes at one year whether patients undergo bypass surgery or angioplasty with stenting, British researchers report.

Bypass surgery has been the standard treatment for diabetic patients with coronary artery disease. However, less invasive approaches such as angioplasty with stenting -- where a thin mesh tube is inserted to open the artery -- have emerged. Until now, there's been little study to see whether the procedure is as effective as bypass in diabetic patients.

"Cardiovascular disease is the leading cause of death among patients with type 2 diabetes, and approximately 25 percent of the patients who undergo revascularization procedures in the United States have type 2 diabetes," noted Dr. Gregg C. Fonarow, a professor of cardiology at the University of California, Los Angeles, who was not involved in the study.

Earlier studies have suggested that bypass surgery provides more effective revascularization (re-opening of blood flow) and better long-term clinical outcomes in patients with type 2 diabetes and multi-vessel coronary artery disease compared to angioplasty/stenting, Fonarow said.

But this new clinical trial in patients with type 2 diabetes and multi-vessel disease suggests that in the first year at least, bypass and angioplasty/stenting produce similar results, he said.

"However, as this study is small and the follow-up period confined only to the first year, additional studies with more patients and longer-term follow-up are required," Fonarow said.

The report is published in the Nov. 25 online edition of the Journal of the American College of Cardiology. The study was funded by a number of drug companies, including Eli Lilly & Co. and Bristol-Myers Squibb, as well as stent manufacturers such as Boston Scientific and Medtronic.

For the study, a team led by Dr. Kevin J. Beatt from the Mayday University Hospital in London, randomly assigned 510 diabetic patients who participated in the Coronary Artery Revascularization in Diabetes Trial to undergo coronary bypass surgery or angioplasty with stenting.

During one year of follow-up, the rate of deaths, heart attack and stroke was 10.5 percent among patients who had bypass surgery, compared with 13 percent for patients who underwent angioplasty and stenting, the researchers found.

The type of stent used seemed important. The first group of patients in the trial received bare metal stents, but when drug-eluting (emitting) stents became available many of the patients received them instead. The introduction of these stents greatly improved the outcome for the patients who received them, the researchers found.

While rates for death, heart attack and stroke were 12.4 percent among patients who underwent bypass surgery, they were 11.6 percent among patients who received drug-eluting stents, the researchers report.

"When the new drug-eluting stents were used, stenting seemed as good and was possibly better than bypass surgery," said Dr. Byron Lee, an associate professor of cardiology at the University of California San Francisco. "However, this finding was based only on a subgroup analysis, and definitive proof will have to await the results of other ongoing trials," he said.

In cardiac bypass surgery, the patient's chest is opened, exposing the heart. The patient is put on a heart-lung machine that continues to pump blood though the body as the operation is done. The operation itself involves taking vein segments from the patient's leg and using them to replace blocked coronary arteries.

In contrast, angioplasty, a minimally invasive procedure, involves passing a catheter from the patient's groin into the blocked heart artery. A balloon at the tip of the catheter opens to expand the blocked artery. To ensure the artery remains open, a stent is placed in the artery. Drug-eluting stents are coated with a drug that promotes healing and helps prevent the stent from becoming blocked again.

More information

For more information on heart surgery, visit the U.S. National Library of Medicine.



SOURCES: Gregg C. Fonarow, M.D., professor, cardiology, University of California, Los Angeles; Byron Lee, M.D., associate professor, cardiology, University of California San Francisco; Nov. 25, 2009, Journal of the American College of Cardiology, online


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. American Heart Association Late Breaking Clinical Trial Report: Tests Predict Which Patients Are Resistant to Anti-Clotting Therapy During Angioplasty, Stenting
2. Stenting a Good Option for Left Main Heart Artery
3. SCAI Statement on A National Study of the Effect of Individual Proton Pump Inhibitors on Cardiovascular Outcomes in Patients Treated with Clopidogrel Following Coronary Stenting: The Clopidogrel Medco Outcomes Study
4. Is Bypass Truly Better than Stenting?
5. Tomophase to Exhibit First In-vivo Cross-sectional Images of Pulmonary Stenting Using Proprietary OCT System
6. SAPPHIRE trial shows long-term benefit of carotid stenting as alternative to surgery
7. NEJM study demonstrates carotid stenting with embolic protection is comparable to surgery
8. Stenting as Good as Surgery for Stroke Prevention
9. Renal artery stenting falls short in large randomized trial
10. The Elderly Can Be Candidates for Angioplasty, Stenting
11. Combined stenting and photodynamic therapy improves survival in late stage liver cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... ... The Dream Builders Project, a 501(c)3 nonprofit organization based in Los Angeles, ... Mexico on Saturday, May 21st. The volunteers took the children out for the day ... 15 volunteers traveled from Los Angeles to Tijuana, Mexico for the day in the ...
(Date:5/24/2016)... ... 2016 , ... Global Lyme Alliance (GLA), a leading nonprofit ... has named Scott Santarella as its new CEO. , Santarella is former ... San Francisco, where he successfully helped to grow the organization from a regional ...
(Date:5/24/2016)... ... ... PhysicianOne Urgent Care, advocators in helping their patients lead the healthiest lives possible, updates ... spring. , The official tick season kicks off in May across the states ... themselves to their prey while they feed off their blood. Like other similar biting ...
(Date:5/24/2016)... ... May 24, 2016 , ... Applications ... multiplex immunoassays are widely used for cell and protein analysis. Keeping updated on ... quality and efficiency in these areas. , LabRoots introduces a new complementary ...
(Date:5/23/2016)... ... May 23, 2016 , ... On the occasion of his 25th Anniversary of ... weight loss process: , New patients have a consultation and evaluation (done by Dr. ... evaluated. , Body Composition Analysis, There are 15 things that each patient gets checked ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... -- Global Paclitaxel Market 2016 Industry Research ... and the Paclitaxel analysis in this study is supported ... its players. This is the latest Paclitaxel ... current state of the industry while providing a basic ... industry chain structure. The Paclitaxel market analysis is provided ...
(Date:5/23/2016)... , May 23, 2016 The World Health ... PrePex device to include adolescents aged 13 years, and ... can be offered for adult and adolescent males in the ... . PrePex was the first male circumcision device to ... MedTech,s CEO, Eddy Horowitz said: " The ...
(Date:5/23/2016)... May 23, 2016   Purdue Pharma L.P. ... an agreement with Egalet Corporation and Acura Pharmaceuticals, ... part of the agreement the companies will exchange ... all three companies to develop and sell several ... "This agreement reflects the commitment of Purdue Pharma ...
Breaking Medicine Technology: